No­var­tis preps a 2020 launch in mul­ti­ple scle­ro­sis as 2 suc­cess­ful piv­otal tri­als set stage for an as­sault on Roche’s new star fran­chise

No­var­tis’ Arz­er­ra ap­pears ready to grab a new lease on block­buster life as the Swiss phar­ma gi­ant rolls out its top-line snap­shot this morn­ing on 2 suc­cess­ful head-to-head stud­ies in mul­ti­ple scle­ro­sis.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER